U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233863) titled 'Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer' on Nov. 14.
Brief Summary: This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Study Start Date: March 18, 2024
Study Type: INTERVENTIONAL
Condition:
Lymphedema Arm
Intervention:
PROCEDURE: Lymphovenous bypass (LVB)
The Lymphovenous Bypass (LVB) procedure in this study is a microsurgical supermicrosurgery-based intervention specifically designed for the secondary prev...